Clinical trial

An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer

NCT06693336

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-11-18

PhasePHASE2

Study timeline

Study start (actual)2024-11-18Date precision: day

Registry last updated2026-09-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)unresolved

Interventions

SMS001DRUG

Sponsors & collaborators

ToLymph Inc.lead sponsor

University Health Network, Torontocollaborator

Mayo Clinic, Rochester, MNcollaborator

Mapped research locations

TorontoOntario, Canada1 RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06693336 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.